Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation.

MLA

Ceballos, Francisco C., et al. “Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation.” Frontiers in Immunology, vol. 13, June 2022, p. 925558. EBSCOhost, https://doi.org/10.3389/fimmu.2022.925558.

APA

Ceballos, F. C., Virseda-Berdices, A., Resino, S., Ryan, P., Martínez-González, O., Peréz-García, F., Martin-Vicente, M., Brochado-Kith, O., Blancas, R., Bartolome-Sánchez, S., Vidal-Alcántara, E. J., Albóniga-Díez, O. E., Cuadros-González, J., Blanca-López, N., Martínez, I., Martinez-Acitores, I. R., Barbas, C., Fernández-Rodríguez, A., & Jiménez-Sousa, M. Á. (2022). Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation. Frontiers in Immunology, 13, 925558. https://doi.org/10.3389/fimmu.2022.925558

Chicago

Ceballos, Francisco C, Ana Virseda-Berdices, Salvador Resino, Pablo Ryan, Oscar Martínez-González, Felipe Peréz-García, María Martin-Vicente, et al. 2022. “Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation.” Frontiers in Immunology 13 (June): 925558. doi:10.3389/fimmu.2022.925558.